JP2020514378A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020514378A5 JP2020514378A5 JP2019551443A JP2019551443A JP2020514378A5 JP 2020514378 A5 JP2020514378 A5 JP 2020514378A5 JP 2019551443 A JP2019551443 A JP 2019551443A JP 2019551443 A JP2019551443 A JP 2019551443A JP 2020514378 A5 JP2020514378 A5 JP 2020514378A5
- Authority
- JP
- Japan
- Prior art keywords
- secretion
- expression
- level
- item
- tumor antigens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023030903A JP2023063330A (ja) | 2017-03-20 | 2023-03-01 | 処置方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762473899P | 2017-03-20 | 2017-03-20 | |
| US62/473,899 | 2017-03-20 | ||
| US201762484258P | 2017-04-11 | 2017-04-11 | |
| US62/484,258 | 2017-04-11 | ||
| US201762583233P | 2017-11-08 | 2017-11-08 | |
| US62/583,233 | 2017-11-08 | ||
| PCT/US2018/023442 WO2018175505A1 (en) | 2017-03-20 | 2018-03-20 | Treatment methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023030903A Division JP2023063330A (ja) | 2017-03-20 | 2023-03-01 | 処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020514378A JP2020514378A (ja) | 2020-05-21 |
| JP2020514378A5 true JP2020514378A5 (enExample) | 2021-04-30 |
Family
ID=63585735
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551443A Withdrawn JP2020514378A (ja) | 2017-03-20 | 2018-03-20 | 処置方法 |
| JP2023030903A Pending JP2023063330A (ja) | 2017-03-20 | 2023-03-01 | 処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023030903A Pending JP2023063330A (ja) | 2017-03-20 | 2023-03-01 | 処置方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10859566B2 (enExample) |
| EP (1) | EP3601536A4 (enExample) |
| JP (2) | JP2020514378A (enExample) |
| KR (1) | KR20190142767A (enExample) |
| CN (1) | CN110651036A (enExample) |
| AU (1) | AU2018240199A1 (enExample) |
| BR (1) | BR112019019407A2 (enExample) |
| CA (1) | CA3055791A1 (enExample) |
| IL (1) | IL269371A (enExample) |
| MX (1) | MX2019011148A (enExample) |
| SG (1) | SG11201908530QA (enExample) |
| WO (1) | WO2018175505A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019019407A2 (pt) | 2017-03-20 | 2020-05-26 | Genocea Biosciences Inc. | Métodos de tratamento |
| EP3873614A4 (en) | 2018-10-29 | 2022-09-07 | Genocea Biosciences, Inc. | TREATMENT PROCEDURES |
| CN109957549A (zh) * | 2018-12-03 | 2019-07-02 | 胜武（北京）生物科技有限公司 | 一种双功能溶瘤病毒及其应用 |
| US20200179500A1 (en) | 2018-12-05 | 2020-06-11 | Wayne State University | Methods and immunogenic compositions relating to her2 with selective sequence modifications |
| CN110016082B (zh) * | 2018-12-25 | 2021-03-23 | 海南医学院第一附属医院 | MIP3α-FGFR1-PD1/Fc融合蛋白及其核酸分子和应用 |
| WO2020232408A1 (en) * | 2019-05-15 | 2020-11-19 | Genocea Biosciences, Inc. | Treatment methods |
| US20230031980A1 (en) * | 2019-12-13 | 2023-02-02 | Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | Methods and compositions for treating and diagnosing a sage1-related condition |
| WO2021203022A1 (en) * | 2020-04-02 | 2021-10-07 | Genocea Biosciences, Inc. | Treatment methods |
| WO2021231436A1 (en) * | 2020-05-11 | 2021-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic methods for treating covid-19 infections |
| WO2021232200A1 (en) * | 2020-05-18 | 2021-11-25 | Guangdong Tcrcure Biopharma Technology Co., Ltd. | Il-12 armored immune cell therapy and uses thereof |
| US20230243849A1 (en) * | 2020-05-26 | 2023-08-03 | University Of Kentucky Research Foundation | Identifying Risk of Cerebra Edema |
| CN115836122A (zh) * | 2020-08-07 | 2023-03-21 | 基因泰克公司 | 用于预测多肽免疫原性的基于t细胞的方法 |
| WO2022056491A1 (en) * | 2020-09-14 | 2022-03-17 | Genocea Biosciences, Inc. | Treatment methods |
| AU2022233285A1 (en) | 2021-03-09 | 2023-10-19 | Cdr-Life Ag | Mage-a4 peptide-mhc antigen binding proteins |
| US12435444B2 (en) | 2021-03-09 | 2025-10-07 | Cdr-Life Ag | Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same |
| AU2022270155B2 (en) * | 2021-05-07 | 2025-09-11 | University Of North Texas Health Science Center At Fort Worth | Blood test to screen out parkinson's disease |
| WO2023086969A2 (en) | 2021-11-12 | 2023-05-19 | Ichor Medical Systems Inc. | Treatment methods |
| AU2023305322A1 (en) * | 2022-07-14 | 2025-02-27 | Adelaide university | Methods and products for determining responsiveness to anti-pd1 immune checkpoint inhibitor immunotherapy |
| CN120202015A (zh) | 2022-09-14 | 2025-06-24 | Cdr-生物科技股份有限公司 | Mage-a4肽双重t细胞衔接子 |
| CN118955735A (zh) * | 2024-08-02 | 2024-11-15 | 中国药科大学 | 一种融合蛋白及基于其的mRNA递送系统和应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4925661A (en) | 1984-04-19 | 1990-05-15 | Leaf Huang | Target-specific cytotoxic liposomes |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4863874A (en) | 1986-07-11 | 1989-09-05 | The United States Of America As Represented By The Secretary Of The Army | Method for detecting phosphatidylinositol through binding to Concanavalin A |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| US5199942A (en) | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| US5989565A (en) | 1993-01-29 | 1999-11-23 | University Of Pittsburgh | Elution and identification of T cell epitopes from viable cells |
| US5643599A (en) | 1995-06-07 | 1997-07-01 | President And Fellows Of Harvard College | Intracellular delivery of macromolecules |
| US6872518B2 (en) | 1997-09-22 | 2005-03-29 | University Of Rochester | Methods for selecting polynucleotides encoding T cell epitopes |
| US6541011B2 (en) | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
| EP1089751A4 (en) | 1998-06-23 | 2001-07-25 | Univ Leland Stanford Junior | Adjuvant therapy |
| US6004815A (en) | 1998-08-13 | 1999-12-21 | The Regents Of The University Of California | Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells |
| US6407063B1 (en) | 1998-10-02 | 2002-06-18 | Ludwig Institute For Cancer Research | Tumor antigens and CTL clones isolated by a novel procedure |
| WO2000067761A1 (en) | 1999-05-06 | 2000-11-16 | Wake Forest University | Compositions and methods for identifying antigens which elicit an immune response |
| US20030077263A1 (en) | 1999-10-29 | 2003-04-24 | Immunex Corporation | Method of activating dendritic cells |
| US20040002068A1 (en) | 2000-03-01 | 2004-01-01 | Corixa Corporation | Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| US20030003485A1 (en) | 2001-05-15 | 2003-01-02 | Ludwig Institute For Cancer Research | Methods for identifying antigens |
| US7262269B2 (en) | 2001-10-26 | 2007-08-28 | The Regents Of University Of California | Method for screening combinational bead library; ligands for cancer cells |
| DE10164819A1 (de) | 2001-11-20 | 2005-05-19 | Deml, Ludwig, Dr. | Verfahren zur Identifizierung von Zielepitopen der T-Zell-vermittelten Immunantwort und zum Nachweis Epitop-spezifischer T-Zellen |
| US7413868B2 (en) | 2003-11-05 | 2008-08-19 | Trellis Bioscience, Inc. | Use of particulate labels in bioanalyte detection methods |
| EP1715346A1 (en) | 2005-04-22 | 2006-10-25 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Method of identifying CD4+ T cell antigens |
| US20100080792A1 (en) | 2005-06-16 | 2010-04-01 | Dorothee Herlyn | Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen |
| WO2007098255A2 (en) | 2006-02-21 | 2007-08-30 | President And Fellows Of Harvard College | Compositions for and methods of identifying antigens |
| WO2009020553A2 (en) | 2007-08-03 | 2009-02-12 | President And Fellows Of Harvard College | Chlamydia antigens |
| AU2009266924B2 (en) | 2008-07-01 | 2015-12-10 | Genocea Biosciences, Inc. | Antigen screening system |
| KR102095670B1 (ko) | 2010-05-14 | 2020-03-31 | 더 제너럴 하스피톨 코포레이션 | 종양 특이적 신생항원을 확인하는 조성물 및 방법 |
| EP2992000B1 (en) | 2013-05-03 | 2020-07-08 | The Regents of The University of California | Cyclic di-nucleotide induction of type i interferon |
| ME03586B (me) | 2013-05-18 | 2020-07-20 | Univ California | Sastavi i metode za aktiviranje signaliziranja koje je zavisno od .,stimulatora gena za interferon" |
| MA40737A (fr) * | 2014-11-21 | 2017-07-04 | Memorial Sloan Kettering Cancer Center | Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1 |
| ES2764178T3 (es) | 2014-12-16 | 2020-06-02 | Kayla Therapeutics | Dinucleótidos cíclicos fluorados para inducción de citocinas |
| BR112019019407A2 (pt) | 2017-03-20 | 2020-05-26 | Genocea Biosciences Inc. | Métodos de tratamento |
-
2018
- 2018-03-20 BR BR112019019407-0A patent/BR112019019407A2/pt not_active IP Right Cessation
- 2018-03-20 KR KR1020197030751A patent/KR20190142767A/ko not_active Ceased
- 2018-03-20 JP JP2019551443A patent/JP2020514378A/ja not_active Withdrawn
- 2018-03-20 AU AU2018240199A patent/AU2018240199A1/en not_active Abandoned
- 2018-03-20 SG SG11201908530Q patent/SG11201908530QA/en unknown
- 2018-03-20 WO PCT/US2018/023442 patent/WO2018175505A1/en not_active Ceased
- 2018-03-20 US US15/927,067 patent/US10859566B2/en not_active Expired - Fee Related
- 2018-03-20 EP EP18770807.8A patent/EP3601536A4/en not_active Withdrawn
- 2018-03-20 CA CA3055791A patent/CA3055791A1/en active Pending
- 2018-03-20 MX MX2019011148A patent/MX2019011148A/es unknown
- 2018-03-20 CN CN201880033153.2A patent/CN110651036A/zh active Pending
-
2019
- 2019-09-15 IL IL26937119A patent/IL269371A/en unknown
-
2020
- 2020-10-30 US US17/085,027 patent/US20210199644A1/en not_active Abandoned
-
2023
- 2023-03-01 JP JP2023030903A patent/JP2023063330A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thiruvengadam et al. | Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses | |
| da Silva Antunes et al. | Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters | |
| Krueger et al. | Two sequential activation modules control the differentiation of protective T helper-1 (Th1) cells | |
| Day et al. | Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults | |
| Kagina et al. | Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns | |
| Girolomoni et al. | The role of IL‐23 and the IL‐23/TH 17 immune axis in the pathogenesis and treatment of psoriasis | |
| Khader et al. | IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | |
| Zissel et al. | Cellular players in the immunopathogenesis of sarcoidosis | |
| Holowka et al. | Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence | |
| US20210369825A1 (en) | Cd40 and cd40l combo in an adv vaccine vehicle | |
| Takeda et al. | Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8+ T cells during vaccine immunotherapy | |
| Torres et al. | IL-12p40/IL-10 producing preCD8α/Clec9A+ dendritic cells are induced in neonates upon Listeria monocytogenes infection | |
| CN106456677A (zh) | 基于酵母的免疫疗法和i型干扰素敏感性 | |
| Nantanee et al. | Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac | |
| Santos‐Lima et al. | Production of interferon‐gamma, interleukin‐6, and interleukin‐1β by human peripheral blood mononuclear cells stimulated with novel lys‐gingipain synthetic peptides | |
| EP2696891A1 (en) | New vaccines for prevention and treatment of tuberculosis | |
| JP2023502590A (ja) | 免疫療法のための精密医療法 | |
| Lee et al. | Ex vivo responses for interferon‐gamma and proinflammatory cytokine secretion to low‐molecular‐weight antigen MTB12 of Mycobacterium tuberculosis during human tuberculosis | |
| US20160263218A1 (en) | Bystander immune suppression as a predictor for response to a vaccine | |
| Freches et al. | Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice | |
| Maerz et al. | BCG vaccination induces antibacterial effector functions among Vδ1/3 T cells that are associated with protection against tuberculosis | |
| US12565682B2 (en) | Methods of treating cancer | |
| US20240027460A1 (en) | Immunomodulatory clinical biomarker profiles and uses thereof | |
| Laheurte et al. | UCPVax, a CD4 helper peptide vaccine, induces polyfunctional Th1 cells, antibody response, and epitope spreading to improve antitumor immunity | |
| US20160077107A1 (en) | Personalised medicine |